CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tonghua Dongbao Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tonghua Dongbao Pharmaceutical Co Ltd
Dongbao New Village, Tonghua County
Phone: +86 4355088025p:+86 4355088025 TONGHUA, JLN  134123  China Ticker: 600867600867
Business Summary
TONGHUA DONGBAO PHARMACEUTICAL CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides biological products, traditional Chinese medicines and chemical supplements, applied in the treatment of diabetes and cardiovascular and cerebrovascular diseases, among others. The Company's main products portfolio consists of recombinant human insulin bulk drugs and injections, zhennaoning capsules, among others. The Company also provides medical instruments, plastic-steel windows and profiles, and operates property business. The Company distributes its products within domestic markets and to overseas markets.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
3089 Plastics products, not elsewhere classified
3841 Surgical and medical instruments and apparatus
3442 Metal doors, sash, frames, molding, and trim
1531 Operative builders

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JiahongLi 35 3/27/2024 5/1/2019
Chief Accounting Officer JunyuChi 44 5/1/2020 5/1/2020
General Manager, Director ChunshengLeng 48 3/27/2024 1/25/2007
10 additional Officers and Directors records available in full report.

Business Names
Business Name
600867
Tonghua Dongbao Pharmaceutical Co., Ltd.

General Information
Number of Employees: 3,196 (As of 12/31/2023)
Outstanding Shares: 1,993,617,453 (As of 1/29/2024)
Shareholders: 83,609
Stock Exchange: SHA
Fax Number: +86 4355088002


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024